SCHEMBL3178477

SCHEMBL3178477

O=C(Nc1ccccc1)NC1CCC(OCc2c(F)cccc2F)CC1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 13/20 0.72
▸ ALDH1A1 P00352 3/20 0.57
▸ FAAH O00519 2/20 0.53
▸ RAB9A P51151 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ EPHX1 P07099 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.48
▸ KMT2A Q03164 3/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ DRD4 P21917 1/20 0.47
▸ DRD3 P35462 1/20 0.47
▸ NPC1 O15118 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3178470 1.00 EPHX2 (0.72) EPHX2ALDH1A1FAAHRAB9ASMN1; SMN2
SCHEMBL3190084 0.92 EPHX2 (0.68) EPHX2ALDH1A1FAAHRAB9AEPHX1
SCHEMBL3190094 0.92 EPHX2 (0.68) EPHX2ALDH1A1FAAHRAB9AEPHX1
SCHEMBL3182145 0.90 EPHX2 (0.74) EPHX2ALDH1A1RAB9ASMN1; SMN2KDM4E
SCHEMBL3182153 0.90 EPHX2 (0.74) EPHX2ALDH1A1RAB9ASMN1; SMN2KDM4E
SCHEMBL3192516 0.90 EPHX2 (0.66) EPHX2ALDH1A1FAAHRAB9AEPHX1
SCHEMBL3189594 0.90 EPHX2 (0.66) EPHX2ALDH1A1FAAHRAB9AEPHX1
SCHEMBL3189587 0.90 EPHX2 (0.66) EPHX2ALDH1A1FAAHRAB9AEPHX1
SCHEMBL3192506 0.90 EPHX2 (0.66) EPHX2ALDH1A1FAAHRAB9AEPHX1
SCHEMBL3183168 0.90 EPHX2 (0.66) EPHX2ALDH1A1FAAHRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US claimed
US-20160318856-A1 Substituted Urea eIF2alpha Kinase Activators NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-11-03 — — US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318856-A1 Substituted Urea eIF2alpha Kinase Activators EIF2AK1, EIF2A, EIF4A2 EPHX2 3905/4885ALDH1A1 4322/4885FAAH 4078/4885
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885ALDH1A1 293/4885FAAH 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback